Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
MRD-guided Maintenance Post-HCT: Gilteritini vs SorafenibHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmRecruitingPhase 32026-03-20NCT07463651

1 results · Page 1 of 1

Swipe the table sideways for more columns.

2 results · Page 1 of 1

Swipe the table sideways for more columns.